Navigation Links
Cells from the Research Institute of the MUHC on the road to China
Date:3/27/2008

Montreal, 27 March 2008 - The diabetes epidemic is devastating many areas of the world. In China, approximately 20 million people suffer from the disease and the number keeps growing. To meet this massive health challenge, the Chinese government is encouraging researchers from all over the world to collaborate with Chinese scientists in the development of effective diabetes therapies.

To fund an innovative Quebec-Chinese research initiative in this area, the Ministre du Dveloppement conomique, de lInnovation et de lExportation from Quebec recently awarded a grant of $150,000 to Dr. Constantin Polychronakos of the Research Institute of the McGill University Health Centre (MUHC) in Montreal. The funding will be used to establish a partnership with Dr. Du, Director of the Pharmacology Institute of the Chinese Academy of Medical Sciences in Beijing. The collaboration will focus on a new therapeutic approach to preventing type 2 diabetes.

Contrary to popular belief, the pancreas is not the only insulin-producing organ of the body. The thymus also produces a small quantity of insulin. While insufficient to regulate blood glucose levels, this insulin programs the immune system to recognize the peptide as self. In healthy people, this programming prevents pancreatic insulin from being destroyed by an immune reaction. Dr. Polychronakos has studied this mechanism for many years and has succeeded in creating a culture line of insulin-producing thymus cells.

His goal is to find a drug that would trigger these cells to secrete more insulin. This would theoretically increase the bodys tolerance to the hormone and thus reduce the symptoms of diabetes. However, achieving this objective means testing approximately 100,000 different compounds with special high-performance drug screening equipmentprecisely the technology that is available in Dr. Dus laboratory in Beijing.

The collaboration between Dr. Polychronakos and Dr. Du will allow each one to benefit from the others technology. Their research initiative has enormous potential and international scope. The project is expected to get underway no later than fall, 2008.


'/>"/>

Contact: Isabelle Kling
isabelle.kling@muhc.mcgill.ca
514-934-1934
McGill University Health Centre
Source:Eurekalert

Related medicine news :

1. Tumors use enzyme to recruit regulatory T-cells and suppress immune response
2. Brain cells work differently than previously thought
3. Embryonic Stem Cells Repair Human Heart
4. Embryonic Human Stem Cells May Help Repair Heart Muscle, Lab Study Shows
5. Circulating fats kill transplanted pancreas cells, study shows
6. Experimental anti-cancer drug made from corn lillies kills brain tumor stem cells
7. Melanoma drug revs immune cells but cancer cells ignore it
8. Scientists explain how insulin secreting cells maintain their glucose sensitivity
9. Embryonic stem cells used to grow cartilage
10. Molecular probe paints cancer cells in living animals, Stanford researchers find
11. USC researcher identifies stem cells in tendons that regenerate tissue in animal model
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2017)... ... , ... Antoine Dental Center is now offering various types of dental implants to ... a support for prosthetic teeth, such as crowns, bridges, or dentures. An implant is placed ... lasting new root for the tooth. , Several types of dental implants are available, ...
(Date:6/26/2017)... ... June 26, 2017 , ... A new and improved ... women look and feel about themselves and their sexual encounters. A unique medical ... urinary leakage head on with a ground breaking medical technique aimed to give ...
(Date:6/26/2017)... (PRWEB) , ... June 26, 2017 , ... New patients ... from Dr. Angela Cotey, with or without a referral. Dr. Cotey is a trusted ... of this preferred tooth replacement option. , Patients with missing teeth in Fitchburg, WI, ...
(Date:6/25/2017)... ... June 25, 2017 , ... An increase in wetter ... foliage and plants, and along with that; a humdinger of an allergy season. A ... also means an increase in misery-causing grass and weed pollen. , “Our patients ...
(Date:6/24/2017)... ... 24, 2017 , ... Genes Advice, a new company based ... and Texas doctors' offices and clinics. This breakthrough testing is part of the ... the role genes play in determining an individual's tolerance of and reaction to ...
Breaking Medicine News(10 mins):
(Date:5/30/2017)... , May 30, 2017 Therapix Biosciences Ltd. ... specializing in the development of cannabinoid-based drugs, today ... company overview at three upcoming scientific and investor ... LD Micro Invitational: ... Date:                     ...
(Date:5/24/2017)... Va. , May 24, 2017  ivWatch ... Original Equipment Manufacturer (OEM) Board to enable seamless ... with patient monitoring systems, infusion pumps and other ... OEMs will be able to help health care ... and reduced risks related to IV therapy. ...
(Date:5/18/2017)... WHIPPANY, N.J. , May 18, 2017  Two ... Healthcare Businesswomen,s Association (HBA) during its recent 28 th ... New York City.  The event showcases HBA,s longstanding mission ... the business of healthcare. Cindy Powell-Steffen ... in Bayer,s U.S. Radiology division, and Libby Howe ...
Breaking Medicine Technology: